Legacy Wealth Management (Idaho)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-70
Closed -$8.42K – 655
2026
Q1
$8.42K Buy
70
+64
+1,067% +$7.39K ﹤0.01% 527
2025
Q4
$632 Hold
6
– – ﹤0.01% 805
2025
Q3
$504 Sell
6
-10
-63% -$824 ﹤0.01% 682
2025
Q2
$1.27K Sell
16
-3
-16% -$238 ﹤0.01% 567
2025
Q1
$1.71K Hold
19
– – ﹤0.01% 568
2024
Q4
$1.66K Sell
19
-111
-85% -$11.4K ﹤0.01% 523
2024
Q3
$12.8K Buy
+130
New +$15.4K 0.01% 276

Other funds holding MRK

Legacy Wealth Management (Idaho)'s MRK Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of Merck (MRK) in Q2 2026, closing a stake of 70 shares — an estimated $8.42K sold.

Legacy Wealth Management (Idaho) first reported a position in MRK in Q3 2024 and held it in 7 quarters. The position peaked at $12.8K in Q3 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 70 Merck shares in Q2 2026, an estimated $8.42K.
  • Legacy Wealth Management (Idaho) first reported a position in Merck in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s Merck position peaked at $12.8K in Q3 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.